| Blake G Welling, MD | |
|
4403 Harrison Blvd, #1815, Ogden, UT 84403-3339 | |
| (801) 732-5900 | |
| (801) 217-2327 |
| Full Name | Blake G Welling |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 37 Years |
| Location | 4403 Harrison Blvd, Ogden, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710151980 | NPI | - | NPPES |
| 00011969 | Other | UT | PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 973449171205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mckay Dee Hospital | Ogden, UT | Hospital |
| Ogden Regional Medical Center | Ogden, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ogden Clinic Specialty Services Llc | 1658781422 | 106 |
News Archive
Australian paramedics are leading the world by introducing a new drug, droperidol, to quickly and safely calm violent patients fueled by alcohol and drugs.
EvoLife Laboratories, a world leader in the development of products for skin, oral, nail, hair, hygiene care specifically designed for cancer patients undergoing chemotherapy and radiotherapy, successfully launched its products in the USA. EvoLife Laboratories is present at the annual Oncology Nursing Society Congress 2010 in San Diego and utilizes this opportunity to further engage with nurses and caregivers.
New insights into what causes uncontrollable bleeding in hemophilia patients are provided in a study published by Cell Press on November 20th in the Biophysical Journal. By revealing that blood clots spread in traveling waves through vessels, the study offers new strategies that could lead to the development of more effective treatments for hemophilia as well as common cardiovascular disorders.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that on August 25, 2010, the United States District Court for the District of Columbia denied sanofi-aventis U.S. LLC's request for a preliminary injunction directing the FDA to suspend and withdraw its approval of the Abbreviated New Drug Application (ANDA) filed by the Company's collaboration partner, Sandoz, for enoxaparin sodium injection USP, a generic version of Lovenox®. The decision is subject to appeal.
› Verified 6 days ago
| Entity Name | Ogden Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578550083 PECOS PAC ID: 9638078033 Enrollment ID: O20040105000780 |
News Archive
Australian paramedics are leading the world by introducing a new drug, droperidol, to quickly and safely calm violent patients fueled by alcohol and drugs.
EvoLife Laboratories, a world leader in the development of products for skin, oral, nail, hair, hygiene care specifically designed for cancer patients undergoing chemotherapy and radiotherapy, successfully launched its products in the USA. EvoLife Laboratories is present at the annual Oncology Nursing Society Congress 2010 in San Diego and utilizes this opportunity to further engage with nurses and caregivers.
New insights into what causes uncontrollable bleeding in hemophilia patients are provided in a study published by Cell Press on November 20th in the Biophysical Journal. By revealing that blood clots spread in traveling waves through vessels, the study offers new strategies that could lead to the development of more effective treatments for hemophilia as well as common cardiovascular disorders.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that on August 25, 2010, the United States District Court for the District of Columbia denied sanofi-aventis U.S. LLC's request for a preliminary injunction directing the FDA to suspend and withdraw its approval of the Abbreviated New Drug Application (ANDA) filed by the Company's collaboration partner, Sandoz, for enoxaparin sodium injection USP, a generic version of Lovenox®. The decision is subject to appeal.
› Verified 6 days ago
| Entity Name | Ogden Clinic Specialty Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114203668 PECOS PAC ID: 1658781422 Enrollment ID: O20201105001806 |
News Archive
Australian paramedics are leading the world by introducing a new drug, droperidol, to quickly and safely calm violent patients fueled by alcohol and drugs.
EvoLife Laboratories, a world leader in the development of products for skin, oral, nail, hair, hygiene care specifically designed for cancer patients undergoing chemotherapy and radiotherapy, successfully launched its products in the USA. EvoLife Laboratories is present at the annual Oncology Nursing Society Congress 2010 in San Diego and utilizes this opportunity to further engage with nurses and caregivers.
New insights into what causes uncontrollable bleeding in hemophilia patients are provided in a study published by Cell Press on November 20th in the Biophysical Journal. By revealing that blood clots spread in traveling waves through vessels, the study offers new strategies that could lead to the development of more effective treatments for hemophilia as well as common cardiovascular disorders.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that on August 25, 2010, the United States District Court for the District of Columbia denied sanofi-aventis U.S. LLC's request for a preliminary injunction directing the FDA to suspend and withdraw its approval of the Abbreviated New Drug Application (ANDA) filed by the Company's collaboration partner, Sandoz, for enoxaparin sodium injection USP, a generic version of Lovenox®. The decision is subject to appeal.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Blake G Welling, MD 4403 Harrison Blvd, #1815, Ogden, UT 84403-3339 Ph: (801) 732-5900 | Blake G Welling, MD 4403 Harrison Blvd, #1815, Ogden, UT 84403-3339 Ph: (801) 732-5900 |
News Archive
Australian paramedics are leading the world by introducing a new drug, droperidol, to quickly and safely calm violent patients fueled by alcohol and drugs.
EvoLife Laboratories, a world leader in the development of products for skin, oral, nail, hair, hygiene care specifically designed for cancer patients undergoing chemotherapy and radiotherapy, successfully launched its products in the USA. EvoLife Laboratories is present at the annual Oncology Nursing Society Congress 2010 in San Diego and utilizes this opportunity to further engage with nurses and caregivers.
New insights into what causes uncontrollable bleeding in hemophilia patients are provided in a study published by Cell Press on November 20th in the Biophysical Journal. By revealing that blood clots spread in traveling waves through vessels, the study offers new strategies that could lead to the development of more effective treatments for hemophilia as well as common cardiovascular disorders.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that on August 25, 2010, the United States District Court for the District of Columbia denied sanofi-aventis U.S. LLC's request for a preliminary injunction directing the FDA to suspend and withdraw its approval of the Abbreviated New Drug Application (ANDA) filed by the Company's collaboration partner, Sandoz, for enoxaparin sodium injection USP, a generic version of Lovenox®. The decision is subject to appeal.
› Verified 6 days ago
Dennis Damian Winters, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4403 Harrison Blvd, Suite 1815, Ogden, UT 84403 Phone: 801-387-6520 Fax: 801-387-6525 | |
Kurt D Bangerter, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4403 Harrison Blvd, Ste 1815, Ogden, UT 84403 Phone: 801-732-5900 Fax: 801-732-5988 | |
Jeffrey Clay Aucoin, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4403 Harrison Blvd Ste 1815, Ogden, UT 84403 Phone: 801-732-5900 Fax: 801-732-5988 |